Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Feb;40(2):302–306. doi: 10.1128/aac.40.2.302

Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids.

B W Petschow 1, R P Batema 1, L L Ford 1
PMCID: PMC163106  PMID: 8834870

Abstract

Previous studies have shown that various short- and medium-chain free fatty acids (FFAs) and their corresponding monoacylglycerol esters (MGs) have antibacterial activity in vitro against primarily gram-positive bacteria. More recent studies have also shown that the growth of Helicobacter spp. is inhibited by linoleic acid and arachidonic acid. The purpose of the present study was to evaluate the susceptibility of Helicobacter pylori to the in vitro bactericidal properties of medium-chain MGs and FFAs. Incubation of H. pylori with saturated MGs, ranging in carbon chain length from C10:0 to C14:0, at 1 mM caused a 4-log-unit or greater reduction in the number of viable bacteria after exposure for 1 h. Lower levels of bactericidal activity were observed with C9:0, C15:0, and C16:0 MGs. In contrast, lauric acid (C12:0) was the only medium-chain saturated FFA with bactericidal activity against H. pylori. The MGs and FFAs were bactericidal after incubation for as little as 15 min at neutral or acidic pHs. Higher levels of MGs and FFAs were required for bactericidal activity in the presence of higher amounts of protein in liquid diets. We also found that the frequency of spontaneous development of resistance by H. pylori was higher for metronidazole and tetracycline (10(-5) to 10(-6)) than for C10:0 MG, C12:0 MG, and C12:0 FFA (< 10(-8)). Collectively, our data demonstrate that H. pylori is rapidly inactivated by medium-chain MGs and lauric acid and exhibits a relatively low frequency of spontaneous development of resistance to the bactericidal activity of MGs. Further studies are needed to establish whether MGs may be useful either alone or with other known therapeutic agents in the management of H. pylori infections in humans.

Full Text

The Full Text of this article is available as a PDF (192.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORGSTROM B., DAHLQVIST A., LUNDH G., SJOVALL J. Studies of intestinal digestion and absorption in the human. J Clin Invest. 1957 Oct;36(10):1521–1536. doi: 10.1172/JCI103549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bayliss M. Effect of the Chemical Constitution of Soaps upon their Germicidal Properties. J Bacteriol. 1936 May;31(5):489–504. doi: 10.1128/jb.31.5.489-504.1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Christensen A. H., Logan R. P., Noach L. A., Gjørup T. Do clinicians accept the role of Helicobacter pylori in duodenal ulcer disease: a survey of European gastroenterologists and general practitioners. J Intern Med. 1994 Nov;236(5):501–505. doi: 10.1111/j.1365-2796.1994.tb00836.x. [DOI] [PubMed] [Google Scholar]
  4. Conley A. J., Kabara J. J. Antimicrobial action of esters of polyhydric alcohols. Antimicrob Agents Chemother. 1973 Nov;4(5):501–506. doi: 10.1128/aac.4.5.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Faber J., Goldstein R., Blondheim O., Stankiewicz H., Darwashi A., Bar-Maor J. A., Gorenstein A., Eidelman A. I., Freier S. Absorption of medium chain triglycerides in the stomach of the human infant. J Pediatr Gastroenterol Nutr. 1988 Mar-Apr;7(2):189–195. doi: 10.1097/00005176-198803000-00006. [DOI] [PubMed] [Google Scholar]
  6. Fernandes P. B., Hanson C. W., Stamm J. M., Vojtko C., Shipkowitz N. L., St Martin E. The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo. J Antimicrob Chemother. 1987 Apr;19(4):449–465. doi: 10.1093/jac/19.4.449. [DOI] [PubMed] [Google Scholar]
  7. Galbraith H., Miller T. B. Effect of long chain fatty acids on bacterial respiration and amino acid uptake. J Appl Bacteriol. 1973 Dec;36(4):659–675. doi: 10.1111/j.1365-2672.1973.tb04151.x. [DOI] [PubMed] [Google Scholar]
  8. Galbraith H., Miller T. B. Physicochemical effects of long chain fatty acids on bacterial cells and their protoplasts. J Appl Bacteriol. 1973 Dec;36(4):647–658. doi: 10.1111/j.1365-2672.1973.tb04150.x. [DOI] [PubMed] [Google Scholar]
  9. Glassman H. N. SURFACE ACTIVE AGENTS AND THEIR APPLICATION IN BACTERIOLOGY. Bacteriol Rev. 1948 Jun;12(2):105–148. doi: 10.1128/br.12.2.105-148.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Glupczynski Y., Burette A., De Koster E., Nyst J. F., Deltenre M., Cadranel S., Bourdeaux L., De Vos D. Metronidazole resistance in Helicobacter pylori. Lancet. 1990 Apr 21;335(8695):976–977. doi: 10.1016/0140-6736(90)91043-a. [DOI] [PubMed] [Google Scholar]
  11. Graham D. Y., Lew G. M., Malaty H. M., Evans D. G., Evans D. J., Jr, Klein P. D., Alpert L. C., Genta R. M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb;102(2):493–496. doi: 10.1016/0016-5085(92)90095-g. [DOI] [PubMed] [Google Scholar]
  12. Hardy D. J., Hanson C. W., Hensey D. M., Beyer J. M., Fernandes P. B. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother. 1988 Nov;22(5):631–636. doi: 10.1093/jac/22.5.631. [DOI] [PubMed] [Google Scholar]
  13. Hazell S. L., Graham D. Y. Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol. 1990 May;28(5):1060–1061. doi: 10.1128/jcm.28.5.1060-1061.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kabara J. J., Swieczkowski D. M., Conley A. J., Truant J. P. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother. 1972 Jul;2(1):23–28. doi: 10.1128/aac.2.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Knapp H. R., Melly M. A. Bactericidal effects of polyunsaturated fatty acids. J Infect Dis. 1986 Jul;154(1):84–94. doi: 10.1093/infdis/154.1.84. [DOI] [PubMed] [Google Scholar]
  16. Marshall B. J. Treatment strategies for Helicobacter pylori infection. Gastroenterol Clin North Am. 1993 Mar;22(1):183–198. [PubMed] [Google Scholar]
  17. Moss S., Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut. 1992 Mar;33(3):289–292. doi: 10.1136/gut.33.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. NIEMAN C. Influence of trace amounts of fatty acids on the growth of microorganisms. Bacteriol Rev. 1954 Jun;18(2):147–163. doi: 10.1128/br.18.2.147-163.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Penston J. G. Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia. Aliment Pharmacol Ther. 1994 Aug;8(4):369–389. doi: 10.1111/j.1365-2036.1994.tb00304.x. [DOI] [PubMed] [Google Scholar]
  20. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988 Jan;94(1):33–40. [PubMed] [Google Scholar]
  21. Rubinstein G., Dunkin K., Howard A. J. The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts. J Antimicrob Chemother. 1994 Sep;34(3):409–413. doi: 10.1093/jac/34.3.409. [DOI] [PubMed] [Google Scholar]
  22. Sheu C. W., Freese E. Lipopolysaccharide layer protection of gram-negative bacteria against inhibition by long-chain fatty acids. J Bacteriol. 1973 Sep;115(3):869–875. doi: 10.1128/jb.115.3.869-875.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thompson L., Cockayne A., Spiller R. C. Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration. Gut. 1994 Nov;35(11):1557–1561. doi: 10.1136/gut.35.11.1557. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES